Synthesis and Characterization of YYGSR-NH2 As a Chemical Starting Poin for Thyroid Theranostic Radiopharmaceutical Development. JFM 2026, 9 (1), 830-841. https://doi.org/10.35451/jfm.v9i1.3856.